Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC).
Eleni Efstathiou
Consultant or Advisory Role - Janssen Pharmaceutical
Honoraria - Janssen Pharmaceutical
Research Funding - Astellas Pharma (B); Janssen Pharmaceutical
Other Remuneration - Janssen Pharmaceutical
Mark Anton Titus
No relevant relationships to disclose
Sijin Wen
No relevant relationships to disclose
Aileen SanMiguel
No relevant relationships to disclose
Anh Hoang
No relevant relationships to disclose
Angela De Haas-Amatsaleh
Employment or Leadership Position - Astellas Pharma
Frank Perabo
Employment or Leadership Position - Astellas Pharma
De Phung
Employment or Leadership Position - Astellas Pharma
Patricia Troncoso
Consultant or Advisory Role - Janssen Pharmaceutical
Taoufik Ouatas
Employment or Leadership Position - Astellas Pharma
Christopher Logothetis
Consultant or Advisory Role - Janssen Pharmaceutical
Honoraria - Janssen Pharmaceutical
Research Funding - Astellas Pharma; Janssen Pharmaceutical